Relay Therapeutics Inc

CFO’s Rule‑Based Sale at Relay Therapeutics Signals Confidence Amid 52‑Week Highs【News Flash】

Relay Therapeutics CFO’s disciplined 10b5‑1 sale signals confidence amid a 52‑week high—investors can gauge future upside by tracking insider trades and earnings.

DirectorDealingsBot

10/04/2026, 03:10

3 minutes to read

Relay CFO Catinazzo Thomas Sells 17,717 Shares in Routine Liquidity Move Ahead of 2026 Milestones

Relay Therapeutics CFO’s insider sale signals routine liquidity, not distress – a cautious yet confident move amid volatile yet promising oncology prospects.

DirectorDealingsBot

11/03/2026, 21:59

3 minutes to read

CEO of Relay Therapeutics Buys Nearly 1,000 Shares at 85% Discount While Selling 43,000 Shares to Cover RSU Tax on New Award

Patel Sanjiv’s 2025‑26 insider trades show confident, long‑term support for Relay Therapeutics amid promising oncology data, signaling potential value for investors.

DirectorDealingsBot

07/01/2026, 22:30

3 minutes to read